Nordson MEDICAL Introduces The New Divert™ ULTRA Line Of Ultra-High- Pressure Stopcocks For Demanding Medical Applications

Loveland, Colorado – August 18, 2026 — Nordson MEDICAL, a Nordson Company (Nasdaq: NDSN), is thrilled to expand its Divert™ line of stopcocks with Divert™ ULTRA, a new line of ultra-high-pressure stopcocks designed to deliver reliable flow control in demanding medical applications.

Available in both one-way and three-way configurations, Divert™ ULTRA stopcocks provide the flexibility needed to support a wide range of clinical and device requirements. With an industry-leading pressure rating of up to 1,500 psi, these stopcocks are engineered to perform in ultra-high-pressure environments without compromising precision or reliability.

Featuring low-torque, ergonomic handles for smooth, intuitive operation and constructed from medical-grade, biocompatible materials, Divert™ ULTRA combines durability, ease of use, and dependable performance. ISO 80369-7-compliant connections further support safe and reliable integration into ultra-high-pressure medical systems.

“As medical technologies continue to evolve, device components must keep pace with increasing performance requirements,” said Jordan Berkel, Senior Product Line Manager at Nordson MEDICAL. “Our primary goal in developing the Divert™ ULTRA stopcocks was to bring together extreme pressure capability, ergonomic design, and ISO 80369-7-compliant connections to help OEMs and clinicians achieve reliable performance in ultra-high-pressure procedures.”

Developed for applications where pressure, precision, and reliability are essential, Divert™ ULTRA helps support consistent performance across a wide range of procedures. Whether integrated into inflation, fluid management, or pressure delivery systems, these stopcocks provide dependable flow control in a compact, easy-to-use design engineered for demanding clinical environments.

To learn more or request samples, visit www.nordsonmedical.com.